{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Advocates for people with hepatitis C have found a way for patients to bypass a major drug company and buy an expensive medication, Ribavirin, at far below the usual price. Starting July 9, when the patent on Ribavirin for use against hepatitis C expires, patients will be able to order the drug from a pharmacy in Pittsburgh, according to the Hepatitis C Action and Advocacy Coalition, a patients' group based in San Francisco.", "headline": {"main": "Group Finds a Way to Offer A Hepatitis C Drug for Less"}, "abstract": "Patient advocates have devised strategy to navigate nation's drug approval and patent laws to let people with hepatitis C buy expensive drug, Ribavirin, at far below usual price; plan involves compounding factory where pharmacists will hand-pack pharmacists will hand-pack imported Ribavirin powder into capsules to fill individual prescriptions; Food and Drug Administration says it will probably not try to stop plan, unless it is unsafe; drug, which alone has no effect on disease, is approved to treat hepatitis C only in combination with another drug, Intron A, combination that seems to eliminate virus in 40 percent to 45 percent of patients; Schering-Plough Corp, only supplier, has bundled two drugs together as Rebetron and refused to sell them separately; plan to circumvent Schering-Plough will both save patients money and let those who have trouble tolerating Intron A combine drug with other interferon brands (M)", "print_page": "14", "word_count": 767, "_id": "4fd20f248eb7c8105d781936", "snippet": "Advocates for people with hepatitis C have found a way for patients to bypass a major drug company and buy an expensive medication, Ribavirin, at far below the usual price.    Starting July 9, when the patent on Ribavirin for use against hepatitis C...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1999/06/30/us/group-finds-a-way-to-offer-a-hepatitis-c-drug-for-less.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "REBETRON"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "SCHERING-PLOUGH CORP"}, {"name": "subject", "value": "INTRON A (DRUG)"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "INTERFERON"}, {"name": "subject", "value": "HEPATITIS"}, {"name": "subject", "value": "RIBAVIRIN (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Denise", "lastname": "GRADY"}], "original": "By DENISE GRADY"}, "document_type": "article", "pub_date": "1999-06-30T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Viagra, it turns out, has a political side effect. Last year's anti-impotence sensation has led to this year's byproduct: Around the country, more than a half-dozen state legislatures, swayed largely by insurers' coverage of Viagra treatment, have recently passed measures requiring carriers that cover prescription drugs to pay for women's contraceptives as well. More states are expected to follow.", "headline": {"main": "Insurance for Viagra Spurs Coverage for Birth Control"}, "abstract": "New Hampshire Legislature becomes latest of state legislatures around nation, swayed largely by insurers' coverage of Viagra treatment for male impotence, to require carriers that cover prescription drugs to pay for women's contraceptives as well; more states are expected to follow, with 'contraceptive equity' bills introduced in over 30 states; experts say speedy success of so many contraception bills also reflects rising power of women in state legislatures (M)", "print_page": "1", "word_count": 1361, "_id": "4fd20f248eb7c8105d781935", "snippet": "Viagra, it turns out, has a political side effect.    Last year's anti-impotence sensation has led to this year's byproduct: Around the country, more than a half-dozen state legislatures, swayed largely by insurers' coverage of Viagra treatment, have...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1999/06/30/us/insurance-for-viagra-spurs-coverage-for-birth-control.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW HAMPSHIRE"}, {"name": "subject", "value": "SEX"}, {"name": "subject", "value": "MEN"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "IMPOTENCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "VIAGRA (DRUG)"}, {"name": "subject", "value": "WOMEN"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "BIRTH CONTROL AND FAMILY PLANNING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Carey", "lastname": "GOLDBERG"}], "original": "By CAREY GOLDBERG"}, "document_type": "article", "pub_date": "1999-06-30T00:00:00Z", "section_name": "Front Page; Health; U.S."}], "meta": {"hits": 2, "offset": 0, "time": 46}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}